J I Rojas
Overview
Explore the profile of J I Rojas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rojas J, Gracia F, Parciak T, Alonso R, Becker J, Trevino-Frenk I, et al.
Rev Neurol
. 2024 Mar;
78(7):185-197.
PMID: 38502167
Introduction: The primary objective of the core data set is to reduce heterogeneity and promote harmonization among data sources in EM, thereby reducing the time needed to execute real life...
2.
Cristiano E, Patrucco L, Ysrraelit M, Alonso R, Balbuena M, Ballario C, et al.
Rev Neurol
. 2020 Dec;
72(1):23-32.
PMID: 33378076
Introduction: The identification, diagnosis, follow-up, and treatment of patients with secondary progressive multiple sclerosis (SPMS) show significant differences between health care professionals in Argentina. Aim: To provide consensus recommendations on...
3.
Cristiano E, Patrucco L, Rojas J, Nunez S
Mult Scler Relat Disord
. 2020 Jun;
44:102307.
PMID: 32563927
No abstract available.
4.
Marrodan M, Bensi C, Pappolla A, Rojas J, Gaitan M, Ysrraelit M, et al.
Mult Scler Relat Disord
. 2019 Dec;
39:101892.
PMID: 31846866
Background: Although solid information on the natural history of primary progressive multiple sclerosis (PPMS) is available, evidence regarding impact of disease activity on PPMS progression remains controversial. Objective: To describe...
5.
Rojas J, Sanchez F, Caro F, Miguez J, Patrucco L, Funes J, et al.
J Clin Neurosci
. 2018 Nov;
59:175-178.
PMID: 30401571
The objective of our study was to evaluate the relationship of percentage of annualized brain volume loss (aBVL) and no evidence of disease activity (NEDA) in multiple sclerosis (MS) patients...
6.
Rojas J, Sanchez F, Patrucco L, Miguez J, Besada C, Cristiano E
Neurol Res
. 2017 Mar;
39(7):596-600.
PMID: 28245725
Methods: A case-control study that included patients with relapsing-remitting MS (RRMS) defined by validated criteria, over 18 years of age, with less than three years from disease onset, EDSS ≤ ...
7.
Garcia Basalo M, Fernandez M, Ojea Quintana M, Rojas J, Garcia Basalo M, Bogliotti E, et al.
Arch Gerontol Geriatr
. 2017 Jan;
70:67-75.
PMID: 28088604
Background: Early detection of neurodegenerative diseases is essential for treatment and proper care of these patients. Screening tools available today are effective for several types of dementia. However, there is...
8.
Rojas J, Patrucco L, Miguez J, Sinay V, Cassara F, Caceres F, et al.
J Clin Neurosci
. 2017 Jan;
38:84-86.
PMID: 28087187
Methods: multicenter study that included patients from 14 MS Centers of Argentina. Patients with definite MS with birth years ranging from 1940 to 1989 were included. Gender ratios were calculated...
9.
Cristiano E, Patrucco L, Miguez J, Giunta D, Correale J, Fiol M, et al.
Mult Scler Relat Disord
. 2016 Sep;
9:91-4.
PMID: 27645351
Unlabelled: In 1996, the prevalence of multiple sclerosis (MS) for the metropolitan area of Buenos Aires using the capture-recapture method was estimated to be between 14 and 19.8 cases per...
10.
Cristiano E, Patrucco L, Miguez J, Giunta D, Peroni J, Rojas J
Neurol Sci
. 2016 Jun;
37(10):1621-6.
PMID: 27338941
Studies in multiple sclerosis (MS) suggest a trend of increasing disease prevalence and incidence, and especially, a disproportional increase in the incidence of multiple sclerosis in women. The objective of...